Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2025 and passing over of dividend on equity as well as preference shares for the said Financial Year